LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -34.13%2.08M | 78.38%1.73M | 32.01%1.77M | 20.97%8.53M | 126.78%3.06M | 74.75%3.16M | -59.92%970.22K | -8.96%1.34M | 227.48%7.05M | 1.35M |
Selling and administrative expenses | -52.71%1.01M | 4.20%1.12M | 63.77%1.01M | 117.22%6.5M | 5,067.33%2.67M | 191.39%2.14M | -32.65%1.07M | -0.49%614.24K | 288.53%2.99M | --51.66K |
-General and administrative expense | -52.71%1.01M | 4.20%1.12M | 63.77%1.01M | 117.22%6.5M | 5,067.33%2.67M | 191.39%2.14M | -32.65%1.07M | -0.49%614.24K | 288.53%2.99M | --51.66K |
Research and development costs | 5.14%1.07M | 708.26%614.46K | 180.66%762.28K | -33.11%1.57M | -56.25%387.12K | 42.00%1.02M | -137.50%-101.02K | -43.30%271.61K | 243.56%2.35M | --884.76K |
Other operating expenses | ---- | ---- | ---- | -73.39%453.55K | --0 | ---- | ---- | 20.98%453.55K | 144.32%1.7M | --411.3K |
Operating profit | 34.13%-2.08M | -78.38%-1.73M | -32.01%-1.77M | -20.97%-8.53M | -126.78%-3.06M | -74.75%-3.16M | 59.92%-970.22K | 8.96%-1.34M | -227.48%-7.05M | -1.35M |
Net non-operating interest income expense | 108.83%37.75K | 113.31%39.4K | 3,149.97%50.42K | -33,619.94%-3.46M | -154,544.45%-2.73M | -18,440.62%-427.73K | -12,681.30%-295.89K | 57.20%-1.65K | 57.95%-10.25K | -1.77K |
Non-operating interest income | ---- | --39.4K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non-operating interest expense | ---- | ---- | ---- | 33,619.94%3.46M | ---- | ---- | 12,681.30%295.89K | ---- | -57.95%10.25K | --1.77K |
Total other finance cost | -108.83%-37.75K | ---- | -3,149.97%-50.42K | ---- | ---- | --427.73K | ---- | --1.65K | ---- | ---- |
Other net income (expense) | ||||||||||
Income before tax | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | -1.35M |
Income tax | ||||||||||
Net income | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | -1.35M |
Net income continuous Operations | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | ---1.35M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | -1.35M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | -1.35M |
Basic earnings per share | 46.15%-0.14 | -28.11%-0.11 | -20.00%-0.12 | -60.95%-0.64 | -415.03%-0.3915 | -154.88%-0.26 | 37.09%-0.0859 | 0.04%-0.1 | -169.38%-0.3976 | -0.076 |
Diluted earnings per share | 46.15%-0.14 | -28.11%-0.11 | -20.00%-0.12 | -60.95%-0.64 | -415.03%-0.3915 | -154.88%-0.26 | 37.09%-0.0859 | 0.04%-0.1 | -169.38%-0.3976 | -0.076 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |